Li Mao

Title: Innovations by Inventor Li Mao

Introduction

Li Mao is an accomplished inventor based in Clarksville, MD (US). He has made significant contributions to the field of medical treatments, particularly in the area of ocular pathologies and cancer therapies. With a total of 4 patents, his work focuses on novel strategies that utilize bifunctional molecules to target growth factors.

Latest Patents

Li Mao's latest patents include groundbreaking methods for treating ocular pathologies and cancer. One of his notable inventions is titled "Methods of Treating Ocular Pathologies Using Bifunctional Molecules That Target Growth Factors." This patent outlines innovative approaches for addressing hyperproliferation conditions such as keloids, lung fibrosis, and lung cancer. The methods involve the use of bifunctional molecules that specifically target growth factors. Another significant patent describes a bifunctional hepatoma-derived growth factor (HDGF)-specific antibody. This antibody comprises at least one complementarity determining region (CDR) specific for HDGF and at least one receptor domain that binds to growth factors like vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFβ).

Career Highlights

Li Mao is affiliated with the University System of Maryland, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating serious medical conditions.

Collaborations

Li has collaborated with notable colleagues, including Hening Ren and Xia Hong, who contribute to his research endeavors.

Conclusion

Li Mao's innovative work in developing treatments for ocular pathologies and cancer showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic strategies that could significantly improve patient outcomes.